Consensus Poolbeg Pharma PLC

Equities

POLB

GB00BKPG7Z60

Market Closed - London S.E. Other stock markets 09:05:20 22/05/2024 pm IST			5-day change	1st Jan Change
13.2 ^GBX	+5.60%		+0.38%	+45.86%

01/05	Poolbeg Pharma Secures Full Patent in US for Immunomodulator II	MT
01/05	Poolbeg Pharma celebrates full patent approval for Immunomodulator II	AN

Evolution of the average Target Price on Poolbeg Pharma PLC

Price target over the last 5 years

History of analyst recommendation changes

61394870f87908d3659afcdef9.mdjLpnvcpbFib1OhCrkIAqnwDhglSSOBpcigPJrcdx8.6Jqx0UORydMJFirUeepiMJzJbC5oMRLF1frxBOvsFHHanY-LTKTA5xsIZw~162d2949fec504dffc449781fcb10c69

Analyst Recommendations on Poolbeg Pharma PLC

Time Out revenue rises; Arbuthnot gets rates boost	30/23/30	AN
Proactive's Robin Davison publishes fresh research note on Poolbeg Pharma	09/23/09	AQ

More recommendations

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

0.132 GBP

Average target price

0.21 GBP

Spread / Average Target

+59.09%

High Price Target

0.23 GBP

Spread / Highest target

+74.24%

Low Price Target

0.19 GBP

Spread / Lowest Target

+43.94%

Consensus detail

Consensus revision (last 18 months)

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar